UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma

Cancers, 2020-11, Vol.12 (11), p.3125

2020

Volltextzugriff (PDF)

Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome

Current oncology reports, 2018-04, Vol.20 (4), p.32-14, Article 32

2018

Volltextzugriff (PDF)

CD30‐positive lymphoproliferative disorders—An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre

Australasian journal of dermatology, 2023-05, Vol.64 (2), p.194-203

2023

Volltextzugriff (PDF)

Epigenetic Modifications in Lymphoma and Their Role in the Classification of Lymphomas

Hemato, 2022-03, Vol.3 (1), p.174-187

2022

Volltextzugriff (PDF)

Targeted Approaches to T-Cell Lymphoma

Journal of personalized medicine, 2021-05, Vol.11 (6), p.481

2021

Volltextzugriff (PDF)

3377: Low-dose radiotherapy in primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder

Radiotherapy and oncology, 2024-05, Vol.194, p.S60-S61

2024

Volltextzugriff (PDF)

Pralatrexate and angioimmunoblastic T-cell lymphoma: time for a second look?

Leukemia & lymphoma, 2020-07, Vol.61 (9), p.2031-2033

2020

Volltextzugriff (PDF)

288: Mycosis Fungoides with Large Cell Transformation: Radiotherapy Dose Response and Patient Outcomes

Radiotherapy and oncology, 2024-05, Vol.194, p.S1131-S1133

2024

Volltextzugriff (PDF)

Excellent treatment outcomes from low dose radiation therapy for primary cutaneous CD4+ small/medium T-Cell lymphoproliferative disorder

Radiotherapy and oncology, 2023-01, Vol.178, p.109430, Article 109430

2023

Volltextzugriff (PDF)

Improving disease‐specific survival for patients with Sezary syndrome in the modern era of systemic therapies

British journal of haematology, 2024-07

2024

Volltextzugriff (PDF)

Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides

Bone marrow transplantation (Basingstoke), 2022-11, Vol.57 (11), p.1724-1726

2022

Volltextzugriff (PDF)

Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sézary syndrome

Blood, 2019-10, Vol.134 (16), p.1346-1350

2019

Volltextzugriff (PDF)

Primary cutaneous anaplastic large cell lymphoma and evolving clinical practice: 26 years of skin lesions with locoregional progression to systemic disease

Leukemia & lymphoma, 2020-07, Vol.61 (9), p.2268-2270

2020

Volltextzugriff (PDF)

Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma

Leukemia & lymphoma, 2022-11, Vol.63 (13), p.3217-3221

2022

Volltextzugriff (PDF)

The importance of differentiating between mycosis fungoides with CD30-positive large cell transformation and mycosis fungoides with coexistent primary cutaneous anaplastic large cell lymphoma

Journal of the American Academy of Dermatology, 2021-01, Vol.84 (1), p.185-187

2021

Volltextzugriff (PDF)

IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma

Expert opinion on investigational drugs, 2018-08, Vol.27 (8), p.691-697

2018

Volltextzugriff (PDF)

T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma

Blood advances, 2020-10, Vol.4 (19), p.4640-4647

2020

Volltextzugriff (PDF)

High-dose thiotepa-based conditioning regimens for relapsed lymphoma involving the central nervous system: from "orphan drug" to a standard-of-care?

Leukemia & lymphoma, 2016-01, Vol.57 (1), p.1-3

2016

Volltextzugriff (PDF)

Advances in Frontline Management of Peripheral T-cell Lymphoma

Clinical lymphoma, myeloma and leukemia, 2021-06, Vol.21 (6), p.368-378

2021

Volltextzugriff (PDF)

International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies

Blood advances, 2023-11, Vol.7 (21), p.6639-6647

2023

Volltextzugriff (PDF)

Targeting TAG-72 in cutaneous T cell lymphoma

Heliyon, 2024-09, Vol.10 (17), p.e36298, Article e36298

2024

Volltextzugriff (PDF)

Targeting TAG-72 in cutaneous T cell lymphomaStatement of translational relevance

Heliyon, 2024-09, Vol.10 (17), p.e36298

2024

Volltextzugriff (PDF)

Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study

Leukemia & lymphoma, 2021-01, Vol.62 (2), p.330-336

2021

Volltextzugriff (PDF)

Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome

AIDS (London), 2017-08, Vol.31 (13), p.1839-1845

2017

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(31)
Berichte
(1)

Sprache

Englisch
(32)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Hematology
(13)
Humans
(11)
Oncology
(11)
Mycosis Fungoides
(6)
Cutaneous T-Cell Lymphoma
(5)
Lymphoma
(5)
Dermatology
(4)
Mycosis
(4)
Treatment Outcome
(4)
Hematopoietic Stem Cell Transplantation
(3)
Lymphocytes
(3)
Middle Aged
(3)
Retrospective Studies
(3)
Sézary Syndrome
(3)
T-Cell Lymphoma
(3)
Aged
(2)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)
Ca 72-4
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma

Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome

CD30‐positive lymphoproliferative disorders—An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre

Epigenetic Modifications in Lymphoma and Their Role in the Classification of Lymphomas

Targeted Approaches to T-Cell Lymphoma

3377: Low-dose radiotherapy in primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder

Pralatrexate and angioimmunoblastic T-cell lymphoma: time for a second look?

288: Mycosis Fungoides with Large Cell Transformation: Radiotherapy Dose Response and Patient Outcomes

Excellent treatment outcomes from low dose radiation therapy for primary cutaneous CD4+ small/medium T-Cell lymphoproliferative disorder

Improving disease‐specific survival for patients with Sezary syndrome in the modern era of systemic therapies

Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides

Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sézary syndrome

Primary cutaneous anaplastic large cell lymphoma and evolving clinical practice: 26 years of skin lesions with locoregional progression to systemic disease

Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma

The importance of differentiating between mycosis fungoides with CD30-positive large cell transformation and mycosis fungoides with coexistent primary cutaneous anaplastic large cell lymphoma

IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma

T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma

Incorporation of Machine Learning Tools to Predict Global Outcomes for Patients with Relapsed and Refractory Peripheral T and NK/T-Cell Lymphomas in the Contemporary Era

High-dose thiotepa-based conditioning regimens for relapsed lymphoma involving the central nervous system: from "orphan drug" to a standard-of-care?

Advances in Frontline Management of Peripheral T-cell Lymphoma

International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies

Targeting TAG-72 in cutaneous T cell lymphoma

Targeting TAG-72 in cutaneous T cell lymphomaStatement of translational relevance

Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study

Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome

Suchergebnisse filtern